A new blood-based RNA signature (R(9)), for monitoring effectiveness of tuberculosis treatment in a South Indian longitudinal cohort

Tuberculosis (TB) treatment involves a multidrug regimen for six months, and until two months, it is unclear if treatment is effective. This delay can lead to the evolution of drug resistance, lung damage, disease spread, and transmission. We identify a blood-based 9-gene signature using a computati...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakur, Chandrani, Tripathi, Ashutosh, Ravichandran, Sathyabaarathi, Shivananjaiah, Akshatha, Chakraborty, Anushree, Varadappa, Sreekala, Chikkavenkatappa, Nagaraj, Nagarajan, Deepesh, Lakshminarasimhaiah, Sharada, Singh, Amit, Chandra, Nagasuma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800112/
https://www.ncbi.nlm.nih.gov/pubmed/35118358
http://dx.doi.org/10.1016/j.isci.2022.103745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800112/
https://www.ncbi.nlm.nih.gov/pubmed/35118358
http://dx.doi.org/10.1016/j.isci.2022.103745

Ejemplares similares